These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34334589)

  • 21. Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study.
    Jørgensen JO; Rosenfalck AM; Fisker S; Nyholm B; Fineman MS; Schmitz O; Madsbad S; Holst JJ; Christiansen JS
    Eur J Endocrinol; 2000 Nov; 143(5):593-9. PubMed ID: 11078982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly.
    Giustina A; Bresciani E; Bussi AR; Bollati A; Bonfanti C; Bugari G; Chiesa L; Giustina G
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1333-40. PubMed ID: 7536207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Preoperative Paradoxical GH Response to Oral Glucose Load Predicts a low Risk of Recurrence in Acromegaly.
    Losa M; Garbin E; Calcagnile R; Voltan G; Ceccato F; Scaroni C; Occhi G; Mortini P
    J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38878276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of oral glucose tolerance test (OGTT) 100 g with OGTT 75 g for evaluation of acromegalic patients and the impact of gender on test reproducibility.
    Arafat AM; Müller L; Möhlig M; Mayr B; Kremenevskaya N; Pfeiffer AF; Buchfelder M; Schöfl C
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):685-91. PubMed ID: 21575028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?
    Dobri G; Niwattisaiwong S; Bena JF; Gupta M; Kirwan J; Kennedy L; Hamrahian AH
    Endocrine; 2019 Apr; 64(1):139-146. PubMed ID: 30415402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth Hormone Response to Oral Glucose Load: From Normal to Pathological Conditions.
    Hage M; Kamenický P; Chanson P
    Neuroendocrinology; 2019; 108(3):244-255. PubMed ID: 30685760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly.
    Peracchi M; Porretti S; Gebbia C; Pagliari C; Bucciarelli P; Epaminonda P; Manenti S; Arosio M
    Eur J Endocrinol; 2001 Jul; 145(1):R1-4. PubMed ID: 11415859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
    Mukai K; Otsuki M; Tamada D; Kitamura T; Hayashi R; Saiki A; Goto Y; Arita H; Oshino S; Morii E; Saitoh Y; Shimomura I
    J Clin Endocrinol Metab; 2019 May; 104(5):1637-1644. PubMed ID: 30476255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The altered plasma amino acid pattern is responsible for the paradoxical growth hormone response to the oral glucose tolerance test in liver cirrhosis.
    Martina V; Tagliabue M; Bruno GA; Bonetti G; Brancaleoni V; Meineri I; Saracco G; Zumpano E; Manieri C; Camanni F
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):175-80. PubMed ID: 9579229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous hyperinsulinemia and release of growth hormone following a glucose load as well as in response to thyrotropin releasing hormone in acromegaly.
    Saad MJ; Moreira AC; Foss MC
    Braz J Med Biol Res; 1990; 23(10):953-7. PubMed ID: 2129261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission.
    Kristof RA; Neuloh G; Redel L; Klingmüller D; Schramm J
    J Neurosurg; 2002 Dec; 97(6):1282-6. PubMed ID: 12507124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics.
    Attanasio R; Oppizzi G; Lodrini S; Dallabonzana D; Barausse M; Orlandi P; DaRe N; Cozzi R
    Eur J Endocrinol; 1999 Jan; 140(1):23-8. PubMed ID: 10037247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does SMS 201-995 normalize growth hormone secretion in acromegaly? GH day profiles and GH concentrations after oral glucose loading.
    van Liessum PA; Pieters GF; Smals AG; Swinkels LM; Benraad TJ; Kloppenborg PW
    J Endocrinol Invest; 1989 Sep; 12(8):553-7. PubMed ID: 2592740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body insulin sensitivity rather than body-mass-index determines fasting and post-glucose-load growth hormone concentrations.
    Anderwald CH; Tura A; Gessl A; Smajis S; Bieglmayer C; Marculescu R; Luger A; Pacini G; Krebs M
    PLoS One; 2014; 9(12):e115184. PubMed ID: 25517727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.